Cyclacel Pharmaceuticals (CYCC) Institutional Ownership $0.36 +0.00 (+1.15%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cyclacel Pharmaceuticals (NASDAQ:CYCC)CurrentInstitutional OwnershipPercentage23.58%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$217.08KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.97K Get CYCC Insider Trade Alerts Want to know when executives and insiders are buying or selling Cyclacel Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CYCC Institutional Buying and Selling by Quarter Cyclacel Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024Armistice Capital LLC134,000$217K0.0%N/A9.178% 5/10/2024Acadian Asset Management LLC14,285$29K0.0%-41.0%1.084% 11/1/2022Kestra Advisory Services LLC23,000$34K0.0%N/A0.183% 10/25/2022Raymond James Financial Services Advisors Inc.20,806$30K0.0%-32.5%0.166% 10/18/2022McIlrath & Eck LLC26,342$38K0.0%N/A0.210% 8/15/2022Sio Capital Management LLC454,355$491K0.2%+7.5%4.546% 2/10/2022Acadian Asset Management LLC23,242$89K0.0%N/A0.233% 11/16/2021Two Sigma Advisers LP121,500$640K0.0%+929.7%1.316% 11/15/2021Pura Vida Investments LLC105,141$554K0.0%-33.2%1.139% 11/15/2021Tri Locum Partners LP522,943$2.76M1.1%+66.9%5.663% Get the Latest News and Ratings for CYCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/12/2021Affinity Asset Advisors LLC400,000$2.11M0.5%+5.3%4.332% 11/2/2021Raymond James Financial Services Advisors Inc.10,006$53K0.0%-83.3%0.108% 10/15/2021NEXT Financial Group Inc14,752$77K0.0%+70.0%0.160% 8/18/2021Ikarian Capital LLC100,000$593K0.0%-66.7%1.083% 8/17/2021Boothbay Fund Management LLC10,545$62K0.0%-66.7%0.114% 8/17/2021Citadel Advisors LLC250,797$1.49M0.0%-14.7%2.716% 8/16/2021Tri Locum Partners LP313,331$1.86M0.6%+6.8%3.393% 8/16/2021Schonfeld Strategic Advisors LLC102,525$607K0.0%-25.0%1.110% 8/16/2021Maven Securities LTD234,500$1.43M0.1%-6.2%2.540% 8/13/2021Northern Trust Corp14,957$89K0.0%N/A0.162% 8/13/2021Geode Capital Management LLC50,860$301K0.0%+143.3%0.551% 8/13/2021Vanguard Group Inc.327,658$1.94M0.0%+9.2%3.548% 7/31/2021NEXT Financial Group Inc8,680$51K0.0%N/A0.094% 5/19/2021Virtu Financial LLC13,108$93K0.0%+27.3%0.142% 5/19/2021Squarepoint Ops LLC23,836$169K0.0%N/A0.258% 5/18/2021Point72 Asset Management L.P.230,000$1.64M0.0%N/A2.491% 5/18/2021Verition Fund Management LLC116,674$830K0.0%N/A1.264% 5/18/2021Morgan Stanley100,000$711K0.0%-13.0%1.083% 5/18/2021Citadel Advisors LLC293,867$2.09M0.0%N/A3.182% 5/18/2021Silverarc Capital Management LLC250,000$1.78M1.0%N/A2.707% 5/17/2021Schonfeld Strategic Advisors LLC136,725$972K0.0%N/A1.481% 5/17/2021Sphera Funds Management LTD.508,322$3.61M0.3%N/A5.505% 5/17/2021Ikarian Capital LLC300,000$2.13M0.1%-23.4%3.249% 5/12/2021Geode Capital Management LLC20,904$148K0.0%N/A0.226% 5/12/2021Pura Vida Investments LLC273,958$1.95M0.1%-42.3%2.967% 5/11/2021Acadian Asset Management LLC34,057$242K0.0%N/A0.369% 4/12/2021Valeo Financial Advisors LLC4,500$32K0.0%N/A0.063% 2/24/2021Virtu Financial LLC10,293$80K0.0%N/A0.212% 2/16/2021Pura Vida Investments LLC475,000$3.71M0.1%N/A9.766% 2/16/2021Acuta Capital Partners LLC150,000$1.17M0.3%N/A3.084% Did You See Trump’s Manhattan Project Bombshell? (Ad)This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House. Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)... Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years. Click here and see for yourself.2/12/2021Raymond James Financial Services Advisors Inc.57,006$445K0.0%+24.6%1.172% 2/12/2021Ikarian Capital LLC391,450$3.06M0.1%N/A8.048% (Data available from 1/1/2016 forward) CYCC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CYCC shares? During the previous two years, the following institutional investors and hedge funds held shares of Cyclacel Pharmaceuticals shares: Armistice Capital LLC ($217K), Acadian Asset Management LLC ($29K).Learn more on CYCC's institutional investors. What percentage of Cyclacel Pharmaceuticals stock is owned by institutional investors? 23.58% of Cyclacel Pharmaceuticals stock is owned by institutional investors. Learn more on CYCC's institutional investor holdings. Which institutional investors have been buying Cyclacel Pharmaceuticals stock? The following institutional investors have purchased Cyclacel Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($134K). How much institutional buying is happening at Cyclacel Pharmaceuticals? Institutional investors have bought a total of 134,000 shares in the last 24 months. This purchase volume represents approximately $217.08K in transactions. Which Cyclacel Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Cyclacel Pharmaceuticals stock in the last 24 months: Acadian Asset Management LLC ($9.94K). How much institutional selling is happening at Cyclacel Pharmaceuticals? Institutional investors have sold a total of 9,938 shares in the last 24 months. This volume of shares sold represents approximately $20.97K in transactions. Related Companies Talphera Institutional Ownership Indaptus Therapeutics Institutional Ownership Ensysce Biosciences Institutional Ownership SciSparc Institutional Ownership Biofrontera Institutional Ownership Cyclerion Therapeutics Institutional Ownership Eagle Pharmaceuticals Institutional Ownership Addex Therapeutics Institutional Ownership NLS Pharmaceutics Institutional Ownership Soligenix Institutional Ownership This page (NASDAQ:CYCC) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclacel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYCC Stock Alerts